Two years ago this month, the Nobel Prize in Chemistry was awarded to two of the pioneers of the Crispr DNA-editing technique. Since then, it has displaced all other laboratory techniques for that purpose by virtue of its accuracy, simplicity, ease of use, and low cost.
How it works and why it was Nobel-worthyContinue reading
The National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer and the Center for Advancing Innovation have partnered to create a “first of a kind” Nanotechnology Startup Challenge in Cancer or NSC2.Continue reading
Tempe, Arizona (July 23, 2015) – Using the brightest X-ray laser in the world, scientists have determined the structure of a molecular complex that is responsible for our sense of sight.Continue reading
Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide.Continue reading
After years of delving deep into DNA and researching ways in which metal damage may lead to cancer, a team of researchers is taking a step back to look at the surface where one answer may have been all along.Continue reading
Charlie Arntzen has worked tirelessly on new platforms to deliver vaccines. He has focused on plant-based vaccine delivery systems, testing a wide range of plants as possible “manufacturing platforms” for vaccines for the developing world.Continue reading
UA Researchers Study Increasing Lifespan and Immune FunctionContinue reading
SynCardia Systems, Inc., now controls last key component in heart manufacturing.Continue reading
NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.Continue reading
TUCSON, Ariz. – July 16, 2014 – The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.Continue reading